New sedation strategy aims to boost survival for critically ill elderly
NCT ID NCT06251375
Summary
This study is testing if using a specific sedative drug (dexmedetomidine) early on can help older patients on breathing machines survive longer. It will involve 300 patients aged 65 and older who are critically ill in intensive care. The goal is to see if this approach reduces deaths within 90 days compared to standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.